Abstract
1566
Objectives The role and regulation of the efflux transporter Breast Cancer Resistance Protein (BCRP) at the BBB are not well known compared to the P-glycoprotein (P-gp, MDR1). The hypoglycaemic sulfonylurea glyburide (GLB) has been described has a specific substrate of BCRP. Moreover, this widely prescribed drug can be radiolabeled with carbone-11.
Methods 3H-GLB uptake in human BCRP- and MDR1-MDCKII transfected cells was measured (n=4) with or without addition of specific inhibitors: Fumitremorgin C 10 µM and PSC833 5µM, respectively. The brain transport of 3H-GLB was measured independently from peripheral metabolism or distribution by in situ brain perfusion method in wild-type (WT) mice with or without transport inhibitors (n= 4-7 mice) and in triple deficient Mdr1a/1b(-/-;-/-)Bcrp(-/-) mice. 11C-GLB was obtained by radiomethylation of its O-desmethyl precursor using 11C-methyl-triflate. A PET dynamic acquisition was performed in this P-gp/Bcrp deficient strain and WT mice (n=2 and 3) using a microPET scanner following an IV injection of 11C-GLB (~10 MBq). Brain uptake is reported as mean brain SUV measured at equilibrium from 10 to 18 min post-injection (SUV(10-18)).
Results The uptake of 3H-GLB was increased 3.8 and 2.1-fold in BCRP and MDR1 cells, respectively, in the presence of respective inhibitors. The brain transport of 3H-GLB in WT mice was low (Kin = 0.40 ± 0.05 µL/g/s) and was significantly increased (~1.5-fold) in the presence of P-gp or BCRP chemical inhibitor. In triple deficient mice, Kin was 1.3 ± 0.18 µL/g/s. PET data also revealed a low brain uptake of 11C-GLB with SUV(10-18)= 0.014 ± 0.002 in WT mice. However, this uptake was only increased up to ~1.5-fold in triple deficient mice.
Conclusions GLB is efficiently transported by P-gp and BCRP, both decreasing its brain uptake at the mouse BBB. However, the net brain uptake of 11C-GLB in triple deficient mice is not sufficiently enhanced to consider this tracer as a suitable probe to study P-gp and/or Bcrp efflux at the BBB